{"id":58887,"date":"2015-07-08T14:41:21","date_gmt":"2015-07-08T14:41:21","guid":{"rendered":"http:\/\/mostafa.openonline.co.uk\/?guid=a31529d5e46c681e3e1356dfe34a3fa7"},"modified":"2015-07-08T14:41:21","modified_gmt":"2015-07-08T14:41:21","slug":"news-story-regenerative-medicine-apply-for-8-million-business-funding","status":"publish","type":"post","link":"https:\/\/mostafa.openonline.co.uk\/?p=58887","title":{"rendered":"News story: Regenerative medicine: apply for \u00a38 million business funding"},"content":{"rendered":"
\n

Innovate UK will support innovative medical therapies that aim to replace or regenerate human cells, tissues or organs to restore or establish normal function.<\/p>\n

The competition will support projects that develop regenerative medicines and cell therapies as clinical treatments and commercial products.<\/p>\n

Regenerative medicine could offer treatments in many areas. Around 30% of the UK population suffers from a chronic disease where there is no cure or where treatment is inadequate.<\/p>\n

Recent therapeutic advances have already been demonstrated for conditions such as diabetes, liver disease and blood disorders. Small-scale clinical trials of cell-based cancer immunotherapies have also encouraged increased commercial investment.<\/p>\n

The global market for regenerative medicine and cell therapy is expected to grow from $1 billion to $5 billion before 2020. Regenerative medicine has been recognised by the government as one of the eight great technologies where the UK can be a global leader.<\/p>\n

The competition will support both the clinical development of novel therapies and the development of platform tools and technologies that address product safety or manufacturing challenges.<\/p>\n

Competition information<\/h2>\n